AAAAAA
Results: 1-25/32
Authors:
Yamada, KM
Danen, EHJ
Citation: Km. Yamada et Ehj. Danen, Integrin signaling, CANC DRUG, 5, 2000, pp. 1-25
Authors:
Fedi, P
Aaronson, SA
Citation: P. Fedi et Sa. Aaronson, Signal transduction through tyrosine kinase growth factor receptors, CANC DRUG, 5, 2000, pp. 27-38
Authors:
Roberts, AB
de Caestecker, MP
Lechleider, RJ
Citation: Ab. Roberts et al., Signaling from TGF-beta receptors, CANC DRUG, 5, 2000, pp. 39-51
Authors:
Barish, GD
Williams, BO
Citation: Gd. Barish et Bo. Williams, The Wnt signal transduction pathway, CANC DRUG, 5, 2000, pp. 53-82
Authors:
Fukuhara, S
Marinissen, MJ
Chiariello, M
Gutkind, JS
Citation: S. Fukuhara et al., Signaling from G-protein-coupled receptors to the nucleus, CANC DRUG, 5, 2000, pp. 83-98
Authors:
Sloan-Lancaster, J
Samelson, LE
Citation: J. Sloan-lancaster et Le. Samelson, Proximal events in T-cell activation, CANC DRUG, 5, 2000, pp. 99-111
Authors:
Siraganian, RP
Citation: Rp. Siraganian, Signal transduction from the high affinity IgE receptor, CANC DRUG, 5, 2000, pp. 113-134
Authors:
Siegel, RM
Martin, DA
Hornung, F
Dudley, EC
Zheng, LX
Lenardo, MJ
Citation: Rm. Siegel et al., Signaling through Fas (CD95, APO-1) and related death receptors, CANC DRUG, 5, 2000, pp. 135-152
Authors:
Davis, RJ
Citation: Rj. Davis, Signal transduction to the nucleus by MAP kinase, CANC DRUG, 5, 2000, pp. 153-164
Authors:
Kelly, K
Chu, YF
Citation: K. Kelly et Yf. Chu, The regulation of MAP kinase pathways by MAP kinase phosphatases, CANC DRUG, 5, 2000, pp. 165-182
Authors:
Fanger, GR
Schlesinger, TK
Johnson, GL
Citation: Gr. Fanger et al., Control of MAPK signaling by Ste20-and Ste11-like kinases, CANC DRUG, 5, 2000, pp. 183-211
Authors:
Clark, GJ
O'Bryan, JP
Der, CJ
Citation: Gj. Clark et al., Ras signaling and transformation, CANC DRUG, 5, 2000, pp. 213-230
Authors:
Symons, M
Citation: M. Symons, Signaling pathways controlled by Rho family GTP-binding proteins, CANC DRUG, 5, 2000, pp. 231-245
Authors:
Fruman, DA
Cantley, LC
Citation: Da. Fruman et Lc. Cantley, PI3-kinases - Role in signal transduction, CANC DRUG, 5, 2000, pp. 247-266
Authors:
Tibbetts, RS
Abraham, RT
Citation: Rs. Tibbetts et Rt. Abraham, PI3K-related kinases - Roles in cell-cycle regulation and DNA damage responses, CANC DRUG, 5, 2000, pp. 267-301
Authors:
Wang, JYJ
Citation: Jyj. Wang, Integrative signaling through c-abl - A tyrosine kinase with nuclear and cytoplasmic functions, CANC DRUG, 5, 2000, pp. 303-324
Authors:
Schwartzberg, PL
Citation: Pl. Schwartzberg, Src - A model for regulation of intracellular signaling molecules, CANC DRUG, 5, 2000, pp. 325-345
Authors:
Blumberg, PM
Acs, P
Bhattacharyya, DK
Lorenzo, PS
Citation: Pm. Blumberg et al., Inhibitors of protein kinase C and related receptors for the lipophilic second-messenger sn-1,2-diacylglycerol, CANC DRUG, 5, 2000, pp. 347-364
Authors:
Finkel, T
Sullivan, DM
Citation: T. Finkel et Dm. Sullivan, Reactive oxygen species in proliferative signaling, CANC DRUG, 5, 2000, pp. 365-377
Authors:
Spiegel, S
Milstien, S
Citation: S. Spiegel et S. Milstien, Sphingolipid metabolites in signal transduction, CANC DRUG, 5, 2000, pp. 379-392
Authors:
Larner, AC
Keightley, A
Citation: Ac. Larner et A. Keightley, The Jak/Stat signaling cascade - Its role in the biological effects of interferons, CANC DRUG, 5, 2000, pp. 393-409
Authors:
Ryan, KM
Vousden, KH
Citation: Km. Ryan et Kh. Vousden, Regulation of cell growth and death by p53, CANC DRUG, 5, 2000, pp. 411-427
Authors:
Mercurio, F
Manning, AM
Citation: F. Mercurio et Am. Manning, Regulation of NF-kappa B function - Novel molecular targets for pharmacological intervention, CANC DRUG, 5, 2000, pp. 429-438
Authors:
Mayer, BJ
Citation: Bj. Mayer, Using protein-interaction domains to manipulate signaling pathways, CANC DRUG, 5, 2000, pp. 439-452
Authors:
Levitzki, A
Citation: A. Levitzki, Protein tyrosine kinase inhibitors as novel therapeutic agents, CANC DRUG, 5, 2000, pp. 453-465